Diane Simeone

Dr. Diane Simeone is the Laura and Isaac Perlmutter Professor of Surgery and Pathology at New York University and the Director of the Pancreatic Cancer Center. She also serves as the Associate Director for Translational Research for the Perlmutter Cancer Center at NYU. An internationally renowned pancreatic surgeon and researcher with a long-standing career focus on the treatment of pancreatic cancer and pancreatic cystic tumors, she has performed over 1000 pancreatic resections using state-of-the-art techniques. She has been an innovator in the development of therapeutic clinical trials for pancreatic cancer, and along with her team runs a large clinical research program dedicated to developing an early detection blood test for pancreatic cancer. She has been the recipient of numerous NIH grants (multiple R01s, U01, P50) investigating the molecular mechanisms driving pancreatic metastasis and the development of novel, more effective therapeutic strategies to treat pancreatic cancer patients. She is currently the principal investigator of Precision Promise, an exciting new national clinical trials consortium focused on next-generation clinical trials for patients with pancreatic cancer. Dr. Simeone has published more than 184 studies in leading peer-reviewed journals and currently serves as the chair of the scientific and medical advisory board of the Pancreatic Cancer Action Network and is a member of the scientific advisory board for Let’s Win (Sharing Science Solutions for Pancreatic Cancer). She has previously served as the president of the Society of University Surgeons and the American Pancreatic Association. Dr. Simeone is a member of the Institute of Medicine of the National Academy of Sciences and the National Cancer Institute’s Pancreatic Cancer Task Force.